The ask is now .44. Even though that is a big spread from the bid IMO that isn't exactly expensive considering BV, NOL's and if they are really capable of executing on growing the pharmacy business via growing business and acquisition. What we don't know yet is how profitable and what type of synergy/added new revenue they can drive to the new acquisitions. If they do that well this stock is mult-bag potential once people discover it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.